Breast Cancer

In 2014, Targeting multiple cannabinoid anti-tumour pathways with a resorcinol derivative leads to inhibition of advanced stages of breast cancer BACKGROUND: screened for analogues that could co-target cannabinoid anti-tumour pathways (CBD- and THC-associated) and discovered the compound O-1663. This analogue inhibited Id1, produced a marked stimulation of ROS, up-regulated autophagy and induced apoptosis. You can read…

Know More

In 2015, MassRoots – Does Cannabis Treat Breast Cancer? BACKGROUND: Treating the core disease of breast cancer by inhibiting the ability of cancer cells to spread or simply killing them, cannabis is an undisputed benefit in terms of decreasing the negative side effects of the disease and its treatment. You can read the full article here…

Know More

In 2010, Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition BACKGROUND: Used a genetically engineered animal model of ErbB2-driven metastatic breast cancer (the MMTV-neu mouse) to analyze the antitumoral potential of cannabinoids in this particularly aggressive pathology. You can read the full article here => https://molecular-cancer.biomedcentral.com/articles/10.1186/1476-4598-9-196

Know More

In 2015, Cannabidiol (CBD) Kills Breast Cancer Cells BACKGROUND: Analyzed the effects of the Cannabis sativaconstituent, cannabidiol (CBD), a potent, natural compound with reported activity in breast cancer cell lines, and elucidated its effects on key neoplastic pathways. You can read the full article here => http://reset.me/study/study-cannabidiol-cbd-kills-breast-cancer-cells/#.WWD-mUqtO_Q.twitter

Know More